Searches for some peptides have surged up to 900 per cent on Google in the last year
The FDA usually relies on clinical trials when it is looking at adding a substance to the 503A bulks list, which determines what ingredients compounding pharmacies can use in mixing drugs
The packaging labels of these products may list only natural herbs as ingredients, but analysis has revealed that they contain synthetic cannabinoids
We thank you for your support!
About this article Cite this article Jhang, JF., Yu, WR., Jiang, YH
The FDA has expressed concerns about compounded peptides, particularly those that have not been approved for any medical use